Medical Condition News

RSS

Neuroscientist receives CAREER grant to research on auditory processing and sound localization

Twenty years ago Khaleel A. Razak was an electronics engineering student focused on creating a telephone for hearing-impaired children in Chennai, India. Today he is a neuroscientist at the University of California, Riverside whose research on how the brain processes everyday sounds may lead to therapies for age-related hearing problems and Fragile X Syndrome.

10 Oct 2013

Researchers made breakthrough development in inhibitory therapeutic for hypersensitive allergic reactions

New research published in the journal Nature Chemical Biology shows that a group of scientists, led by faculty at the University of Notre Dame, has made concrete progress toward the development of the first-ever inhibitory therapeutic for Type I hypersensitive allergic reactions.

10 Oct 2013

Study proposes novel treatment for narcolepsy

Lancet Neurology, a prestigious journal in its domain, publishes in its last issue, an article entitled "Pitolisant versus placebo and modafinil in patients with narcolepsy: a double-blind randomised trial" authored by Y. Dauvilliers and others from the HARMONY I study group which proposes a novel treatment for this orphan disease. It is accompanied by a Commentary entitled "A need for new treatments in narcolepsy".

10 Oct 2013

Key findings may have broad implications for future scleroderma therapy

The Scleroderma Research Foundation today said that researchers at The Johns Hopkins University working in a novel mouse model of Stiff Skin Syndrome have made key discoveries that may have broad implications for future scleroderma therapy.

10 Oct 2013

Mechanism preserving genome integrity help develop new therapies against DiGeorge syndrome

An international team of scientists-including researchers at GENYO, the Centre for Genomics and Oncological Research (Pfizer-University of Granada- Andalusian Regional Government)-has described a molecular mechanism that facilitates the defence of the human genome against "bombarding" by mobile DNA sequences.

10 Oct 2013

People with high amounts of abdominal fat are likely to develop memory loss

Although problems with memory become increasingly common as people age, in some persons, memories last long time, even a life time. On the other hand, some people experience milder to substantial memory problems even at an earlier age.

10 Oct 2013

High levels of HDL have been linked to increased breast cancer risks, enhance cancer aggressiveness

High levels of high density lipoprotein (HDL), also known as the "good cholesterol," are thought to protect against heart disease. However, what's good for one disease may not be good for another.

10 Oct 2013

Allegro receives FDA IND approval to initiate Phase II clinical studies of ALG-1001 in AMD, VMT patients

Allegro Ophthalmics, LLC, a company dedicated to establishing Integrin Peptide Therapy as the next-generation pharmaceutical category for the treatment of vascular eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to begin two Phase II clinical studies of ALG-1001.

10 Oct 2013

FDA approves Phase II trial to study effect of injected stem cells in ALS patients

Two patients with amyotrophic lateral sclerosis (ALS) have received stem cell injections to their spinal cords at the University of Michigan Health System - the first two to receive the experimental injections in Michigan as part of a national clinical trial.

10 Oct 2013

Promedior starts Phase 2 clinical trial to evaluate PRM-151 in patients with myelofibrosis

Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, announced today that it has initiated a Phase 2 clinical trial to evaluate PRM-151, its lead product candidate, in patients with myelofibrosis.

10 Oct 2013

Compugen drug candidate prevents autoimmune type I diabetes in animal model

Compugen Ltd., announced today that CGEN-15001, an Fc fusion protein drug candidate derived from a novel immune checkpoint protein discovered by Compugen, has been shown to be highly efficient in preventing the development of disease in a well-accepted animal model of autoimmune type I diabetes, known also as juvenile diabetes.

9 Oct 2013

Alkermes announces plans to advance ALKS 5461 phase 3 program for major depressive disorder

Alkermes plc today announced that it has successfully completed its End-of-Phase 2 interactions with the U.S. Food and Drug Administration (FDA), and the company plans to advance ALKS 5461 into phase 3 development in early 2014.

9 Oct 2013

Study points to new pathways, targets for novel therapies to treat neurodegenerative diseases

Scientists at the Montreal Neurological Institute and Hospital-The Neuro, McGill University, have made important discoveries about a cellular process that occurs during normal brain development and may play an important role in neurodegenerative diseases.

9 Oct 2013

$Study examines use of single-fraction radiation treatment for prostate cancer, bone metastases$

Study examines use of single-fraction radiation treatment for prostate cancer, bone metastases

Justin E. Bekelman, M.D., of the University of Pennsylvania Perelman School of Medicine, Philadelphia, and colleagues conducted a study to examine whether single-fraction radiation treatment, shown to be as effective as multiple-fraction treatment with less potential for harm, has been incorporated into routine clinical practice for Medicare beneficiaries with prostate cancer and at what cost savings.

9 Oct 2013

Experts offer tips for preventing and coping with osteoarthritis

Most everyone is bound to get osteoarthritis -- if they live long enough. That old saying among arthritis experts is backed up by the numbers. The painful and often debilitating joint condition is the most common form of arthritis.

9 Oct 2013

School lunch debit card payment systems linked with lower nutrition and higher calories

To expedite long lunch lines and enable cleaner accounting, about 80 percent of schools use debit cards or accounts that parents can add money to for cafeteria lunch transactions, write David Just and Brian Wansink, professors at the Cornell Center for Behavioral Economics in Child Nutrition Programs.

9 Oct 2013

New ICT tool improves seniors' quality of life and boost autonomy

Led by Barcelona Digital Technology Centre, the European R&D&I project SAAPHO (Secure Active Ageing: Participation and Health for the Old) has developed an ICT tool in prototype phase that will help seniors to monitor their health and the security of their home and avoid social exclusion by means of digital technologies.

9 Oct 2013

Oncosec Medical reports encouraging results from combination study on aggressive melanoma

OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors, has announced positive preliminary animal data demonstrating the benefits of combining the company's ImmunoPulse with anti-CTLA4 and anti-PD1 antibodies.

9 Oct 2013

Widespread prescription of levothyroxine medication may cause more harm than good

A study of patients in the United Kingdom suggests widespread prescribing of the medication levothyroxine sodium to boost thyroid function among patients with borderline high levels of the thyroid-stimulating hormone thyrotropin (a sign of low thyroid function), raising the possibility of overtreatment, according to a study published by JAMA Internal Medicine, a JAMA Network publication.

9 Oct 2013

New combinations of postoperative pain treatment decreased both pain and use of pain relievers

New combinations of postoperative pain treatment decreased both pain and the use of narcotic pain relievers according to two studies presented this week at the 2013 Clinical Congress of the American College of Surgeons.

9 Oct 2013

Medical Condition News

Neuroscientist receives CAREER grant to research on auditory processing and sound localization

Researchers made breakthrough development in inhibitory therapeutic for hypersensitive allergic reactions

Study proposes novel treatment for narcolepsy

Key findings may have broad implications for future scleroderma therapy

Mechanism preserving genome integrity help develop new therapies against DiGeorge syndrome

People with high amounts of abdominal fat are likely to develop memory loss

High levels of HDL have been linked to increased breast cancer risks, enhance cancer aggressiveness

Allegro receives FDA IND approval to initiate Phase II clinical studies of ALG-1001 in AMD, VMT patients

FDA approves Phase II trial to study effect of injected stem cells in ALS patients

Promedior starts Phase 2 clinical trial to evaluate PRM-151 in patients with myelofibrosis

Compugen drug candidate prevents autoimmune type I diabetes in animal model

Alkermes announces plans to advance ALKS 5461 phase 3 program for major depressive disorder

Study points to new pathways, targets for novel therapies to treat neurodegenerative diseases

Study examines use of single-fraction radiation treatment for prostate cancer, bone metastases

Experts offer tips for preventing and coping with osteoarthritis

School lunch debit card payment systems linked with lower nutrition and higher calories

New ICT tool improves seniors' quality of life and boost autonomy

Oncosec Medical reports encouraging results from combination study on aggressive melanoma

Widespread prescription of levothyroxine medication may cause more harm than good

New combinations of postoperative pain treatment decreased both pain and use of pain relievers

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News